|
Market Closed -
Xetra
11:35:15 2026-11-06 EST
|
After hours 11:54:58 | |||
| 1.950 EUR | -2.99% |
|
1.860 | -4.62% |
Company Valuation: Pentixapharm Holding AG
Data adjusted to current consolidation scope
| Fiscal Period: December | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| Market Cap 1 | 73.15 | 36.73 | 49.81 | - | - |
| Change | - | -49.79% | 35.63% | - | - |
| Enterprise Value (EV) 1 | 73.15 | 36.73 | 42.51 | 62.11 | 82.21 |
| Change | - | -49.79% | 15.75% | 46.1% | 32.36% |
| P/E | - | - | -3.24x | -3.05x | -3x |
| PBR | - | - | - | - | - |
| PEG | - | - | - | -0.47x | -1.98x |
| Capitalization / Revenue | 620x | 395x | - | - | - |
| EV / Revenue | 620x | 395x | - | - | - |
| EV / EBITDA | - | - | -2.04x | -2.81x | -3.62x |
| EV / EBIT | -4.31x | -1.85x | -3.02x | -2.51x | -4.42x |
| EV / FCF | - | - | -4.03x | -2.9x | -5.37x |
| FCF Yield | - | - | -24.8% | -34.5% | -18.6% |
| Dividend per Share 2 | - | - | - | - | - |
| Rate of return | - | - | - | - | - |
| EPS 2 | - | - | -0.62 | -0.66 | -0.67 |
| Distribution rate | - | - | - | - | - |
| Net sales 1 | 0.118 | 0.093 | - | - | - |
| EBITDA 1 | - | - | -20.8 | -22.1 | -22.7 |
| EBIT 1 | -16.97 | -19.86 | -14.1 | -24.7 | -18.6 |
| Net income 1 | - | - | -22.3 | -23.5 | -24.1 |
| Net Debt 1 | - | - | -7.3 | 12.3 | 32.4 |
| Reference price 2 | 2.950 | 1.482 | 2.010 | 2.010 | 2.010 |
| Nbr of stocks (in thousands) | 24,795 | 24,783 | 24,783 | - | - |
| Announcement Date | 4/15/25 | 3/25/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | -2.04x | - | 55.9M | |
| 39.94x | 13.51x | 30.01x | 0.5% | 1,216B | |
| 39.86x | 6.69x | 18.83x | 1.96% | 656B | |
| 37.08x | 8.43x | 17.39x | 2.4% | 509B | |
| 21.12x | 5.13x | 12.77x | 2.56% | 384B | |
| 97.32x | 5.95x | 25.36x | 2.32% | 362B | |
| 23.5x | 6.02x | 14.53x | 2.65% | 311B | |
| 24.85x | 4.96x | 13.98x | 1.76% | 293B | |
| 28.41x | 7.33x | 12.69x | 2.19% | 249B | |
| -40.11x | 7.32x | 45.99x | 1.97% | 208B | |
| Average | 30.22x | 7.26x | 18.95x | 2.03% | 418.79B | |
| Weighted average by Cap. | 35.88x | 8.57x | 22.23x | 1.73% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- PTP Stock
- Valuation Pentixapharm Holding AG
Select your edition
All financial news and data tailored to specific country editions
